ranigast max 150 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - ranitidini hydrochloridum - tabletki powlekane - 150 mg
gastranin zdrovit 150 mg tabletki musujące
n.p. pharma sp. z o.o. - ranitidini hydrochloridum - tabletki musujące - 150 mg
raniberl max 150 mg tabletki powlekane
berlin-chemie ag - ranitidini hydrochloridum - tabletki powlekane - 150 mg
riflux 150 mg tabletki powlekane
polfarmex s.a. - ranitidini hydrochloridum - tabletki powlekane - 150 mg
ranisan 75 mg 75 mg tabletki powlekane
pro.med.cs praha a.s. - ranitidinum - tabletki powlekane - 75 mg
calquence
astrazeneca ab - acalabrutinib - białaczka, limfocytowa, przewlekła, komórka b - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.